Vascular Biogenics Ltd.
SEC CIK 1603207 · VBLT · last insider filing 2024-09-26
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Dubin Thomas I H | Director | filed 2023 - 2024 |
| Graney Thomas | Director | filed 2023 - 2024 |
| Feinberg Peter | Director | filed 2023 - 2024 |
| Galen Michele | Director | filed 2023 - 2024 |
| Bock Thomas | Director · Chief Executive Officer | filed 2023 - 2024 |
| Patsi Tuomo | Director | filed 2023 - 2024 |
| Rice Yehuda Michael | Director | filed 2023 - 2024 |
| Hastings David C | Director | filed 2023 - 2023 |
| Kozin Marc D | Director | filed 2023 - 2023 |
| Alon Ruth | Director | filed 2023 - 2023 |
| Ben Zvi Shmuel | Director | filed 2023 - 2023 |
| Harats Dror | Director · Chief Executive Officer | filed 2023 - 2023 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Zagger Kaile A. | CRO and Interim CEO | filed 2024 - 2024 |
| Wagner Joseph P | Chief Scientific Officer | filed 2023 - 2024 |
| Mcpherson Scott Alan | Chief Financial Officer | filed 2023 - 2023 |
| Backenroth Samuel | Chief Financial Officer | filed 2023 - 2023 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.